Caris Life Sciences, Inc. (CAI)
28.30
-0.05
(-0.18%)
USD |
NASDAQ |
Oct 02, 16:00
28.44
+0.14
(+0.49%)
After-Hours: 20:00
Caris Life Sciences EPS Diluted (Quarterly) : -0.0022 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0022 |
| March 31, 2026 | -0.0018 |
| December 31, 2025 | 0.2901 |
| September 30, 2025 | 0.0862 |
| June 30, 2025 | -1.84 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.452 |
| December 31, 2024 | -0.2204 |
| September 30, 2024 | -0.3287 |
| June 30, 2024 | -0.3194 |
| March 31, 2024 | -0.4772 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CareDx, Inc. | 2.071 |
| Natera, Inc. | -0.4674 |
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -2.431 |
| Exagen, Inc. | -0.1323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.637M |
| Revenue (Quarterly) | 263.71M |
| Total Expenses (Quarterly) | 264.35M |
| Enterprise Value | 7.656B |
| Gross Profit Margin (Quarterly) | 68.10% |
| Profit Margin (Quarterly) | -0.24% |
| Earnings Yield | 1.32% |
| Operating Earnings Yield | 1.92% |
| Normalized Earnings Yield | 1.571 |